PSMA imaging features in oligorecurrent prostate cancer

Lab-on-a-chip (microfluidic) technology and patient-derived 3D prostate cancer models for preclinical therapy screening

Multiplexed Detection of Circulating Tumor Cells in Prostate Cancer Using Nanotechnology Platforms

Liquid biopsy approaches to determine tumor cell heterogeneity in advanced prostate cancer: development of resistance, trans- and dedifferentiation

Dissecting the function of RAI2 in anti-androgen resistance in prostate cancer

An integrated approach for drug target validation

Marine Compounds as a Promising Source for the Development of Novel Anticancer Drugs

Selective Targeting of Prostate Cancer using the Warburg Effect

Aggressive Variants of Prostate Cancer: Mechanisms of Transdifferentiation, Development of Resistance and Treatment Optimization

DNA Repair, hypoxia and genomic instability in metastatic prostate cancer: Mechanistic insights and treatment options DRAGOON Study

Preclinical models of prostate cancer research

Targeting DSB repair deficiency in prostate cancer

Synthesis and evaluation of PSMA-targeted imaging reagents

Robotic ultrasound for SBRT of the prostate

Survival prediction of prostate cancer patients from histopathology images and electronic health records

Development of patient-derived xenograft models (PDX) of metastatic prostate cancer

Regulation of tumor cell dormancy in human prostate cancer bone metastasis

Cooperative roles of tumor cell integrins and tumor stroma selectins for primary tumor growth and distant metastasis

PSMA-guided surgical approaches in prostate cancer